2020, Number S1
<< Back Next >>
Acta Pediatr Mex 2020; 41 (S1)
Interpretation of diagnostic tests for the SARS-Cov-2 virus
Díaz-Jiménez IV
Language: Spanish
References: 14
Page: 51-57
PDF size: 364.86 Kb.
ABSTRACT
With a new viral infectious agent causing severe pneumonia identified in Wuhan as
the SARS-Cov-2, the race against time for fast and safe diagnostic methods became
a priority. Currently, for the diagnosis of Covid-19 disease in the acute phase, the RTPCR
technique in the first week and to know the formation of antibodies to infection
after the first week, serology is available with two techniques. ELISA recommended
for clinical use in hospitals and Immunochromatography, more studies are missing to
recommend its use.
REFERENCES
Gorbalenya AE, et.al The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5: 536-44. https://doi.org/10.1038/s41564-020-0695-z.
Padhi A, et al. Laboratory Diagnosis of Novel Coronavirus Disease 2019. En: Shailendra K. Coronavirus Disease 2019. Epidemiology, Pathogenesis, diagnosis and Therapeutics. 5 th ed. Singapore: Springer, 2020; 95-107. https://doi. org/10.1007/978-981-15-4814-7
Secretaría de Salud. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de COVID-19. Secretaría de Salud México. https://www.gob.mx/cms/ uploads/attachment/file/552972/Lineamiento_VE_y_Lab_ Enf_Viral_20.05.20.pdf
Cheng MP, et al. Diagnostic testing for severe acute respiratory syndrome-related Coronavirus-2: A narrative review. Ann Intern Med 2020; M20-1301. doi:10.7326/ M20-1301.
CDC/NIH Biosafety in Microbiological and Biomedical Laboratories. https://www.cdc.gov/labs/pdf/CDCBiosafetyMicrobiologicalBiomedicalLaboratories- 2009-P.PDF
CLSI Document M29 Protection of Laboratory Workers from Occupationally Acquired Infections. https://clsi.org/ standards/products/microbiology/documents/m29
Centers for Disease Control. Refer to Interim Laboratory Safety Guidelines for Handling and Processing Specimens Associated with SARS-CoV-2. https://www.cdc.gov/ coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html
Manual de Instrucciones de uso Xpert Xpress SARS-CoV-2. https://www.cepheid.com/Package%20Insert%20Files/ Xpress-SARS-CoV-2/Xpert%20Xpress%20SARS-CoV-2%20 Assay%20SPANISH%20Package%20Insert%20302-3787- ES%20Rev.%20A.pdf
Biofire RP. Manual de instrucción del usuario. https://docs. biofiredx.com/wp-content/uploads/BFR0000-8303-BioFire- RP2.1-Panel-Instructions-for-Use-EUA-EN.pdf
Federal and Drug Administration. Coronavirus (COVID-19). Update: FDA Informs Public about possible accuracy concerns with abbot id now point of care Test. May 14, 2020. www.fda.gov.
Ai T, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020; 200642. doi:10.1148/ radiol.2020200642.
Sociedad Española de Pediatría. Recomendaciones de la Sociedad Española de Enfermedades infecciosas y Microbiología Clínica sobre el uso de las pruebas de detección de anticuerpos. https://seimc.org.
Juanjuan Zhao, et al Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases https://doi.org/10.1093/cid/ciaa344
Nuccetelli M, et al. SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov 2020; 6: 38. https://doi.org/10.1038/s41420-020-0275-2.
Full text